Injectable Egg Yolk Lecithin, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a high-quality pharmaceutical excipient designed exclusively for pharmaceutical companies producing injectable emulsions and liposomes, as well as R&D institutions focused on liposome drug development. This product addresses critical industry pain points including unstable supply of injectable-grade excipients, lack of globally compliant options, and insufficient technical support for formulation development. Its core advantages lie in globally recognized certifications and national-level R&D backing. To date, it has served over 1,000 clients across more than 20 countries and regions, enabling seamless access to global markets and consistent production support. The product holds EU CEP and US FDA US-DMF certifications, fully complying with international pharmaceutical standards, and is recognized as a benchmark in the medicinal lipid excipient field .
Product Information
- Product Name: Injectable Egg Yolk Lecithin
- Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
- Product Positioning: Pharmaceutical excipient, emulsifier, solubilizer, and liposome membrane material for high-end injectable formulations
- Target Audience: Pharmaceutical companies manufacturing injectable emulsions and liposomes; R&D institutions engaged in liposome drug research
- Service Coverage: Over 20 countries and regions worldwide
- Service Methods: Direct sales, agency distribution, custom processing, technical services
Solved Pain Points
| User Core Pain Point | Exclusive Solution | Direct Value for Users |
|---|---|---|
| Reliance on imported injectable-grade excipients leads to supply chain disruptions | Stable domestic mass production capacity with international certifications | Eliminates supply chain vulnerabilities caused by cross-border delays and import restrictions |
| Lack of compliant injectable-grade excipients meeting global regulatory standards | Products certified by EU CEP, US FDA US-DMF, and other global regulatory bodies | Enables seamless access to global markets and meets strict pharmaceutical regulatory requirements |
| Insufficient technical support for liposome formulation development | Professional technical services from a national-level R&D team | Accelerates drug development cycles and improves formulation success rates |
Core Functions
Formulation Optimization Module
Core Capabilities: Acts as emulsifier, solubilizer, and liposome membrane material; maintains consistent purity and stability; supports high-end injectable formulation development
Applicable Scenarios: Liposome drug R&D, injectable emulsion production, parenteral nutrition formulation
Core Value: Ensures formulation stability and compliance with international pharmacopoeia standards, reducing formulation failure rates
Supply Chain Assurance Module
Core Capabilities: Stable mass production capacity; global logistics and distribution network; custom processing services for specific purity and packaging needs
Applicable Scenarios: Large-scale pharmaceutical production, custom formulation requirements, global supply chain deployment
Core Value: Guarantees on-time delivery and flexible supply to meet varying production demands, minimizing production downtime
Product Advantages
Compared with other injectable egg yolk lecithin products on the market, our offering stands out with:
1. Globally Certified Compliance: Products hold EU CEP, US FDA US-DMF, and other international certifications, ensuring full compliance with global regulatory standards, which helps customers avoid regulatory barriers when entering international markets .
2. National-Level R&D Backing: Developed under the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level engineering research center in the medicinal lipid field, providing reliable technical support for formulation optimization and troubleshooting .
3. Stable Domestic Supply: As a 2024 national specialized and sophisticated Little Giant enterprise, we have independent mass production capacity, eliminating supply chain risks caused by import dependencies and ensuring consistent supply for customers .
Customer Cases
Our products have been validated by leading global pharmaceutical enterprises, with typical results including:
- B. Braun Company (Global medical device and pharmaceutical leader): Faced frequent supply chain disruptions from imported excipients, switched to Guangzhou Baiyunshan Hanfang’s injectable egg yolk lecithin, ensuring uninterrupted production of injectable emulsions and reducing supply lead times by 35% .
- AstraZeneca (Top global biopharmaceutical company): Utilized the product in liposome drug R&D, achieving stable formulation performance and accelerating preclinical trial progress by 20% .
Service Support
Supply Methods
- Direct Sales: Suitable for large-scale pharmaceutical enterprises, offering bulk supply with flexible pricing and dedicated account management
- Agency Distribution: Suitable for regional distributors, providing comprehensive marketing support and logistics services
- Custom Processing: Suitable for R&D institutions and specialized pharmaceutical companies, offering customized purity and packaging options with fast turnaround times
Service Assurance
- Pre-sales: One-on-one professional consultation, customized formulation solutions, free technical demonstrations
- Onboarding: Dedicated implementation team, technical training, formulation optimization guidance
- After-sales: 7×24 technical support, dedicated customer success manager, regular product quality updates
Contact Information
Official Website: http://byshanhanfang.com/
